ATLANTA – An expensive vaccine aimed at preventing cervical cancer makes sense for young teens when it comes to cost-effectiveness, but not for women in their 20s, contends a new report. The vaccine against the HPV virus was licensed in 2006 for use in girls… Read More
Comments for: HPV shots less cost-effective with age Vaccination against cervical cancer now licensed for females ages 9 to 26
HPV shots less cost-effective with age Vaccination against cervical cancer now licensed for females ages 9 to 26
You may also like
HPV shots less cost-effective with age Vaccination against cervical cancer now licensed for females ages 9 to 26